Pour atteindre les objectifs de sa stratégie et se
rapprocher de la cible de l’ODD 3 liée aux trois
maladies à l’horizon 2030, le Fonds mondial doit
réunir 18 milliards de dollars US pour sa huitième
reconstitution des ressources. Cette somme est
le minimum requis pour faire progresser... la lutte
contre le VIH, la tuberculose et le paludisme à
un rythme correspondant aux objectifs et pour
maintenir les investissements nécessaires dans les
systèmes de santé et communautaires.
more
Damit wir die Meilensteine der Strategie des Globalen
Fonds für 2028 einhalten können und SDG 3 für uns weiter
erreichbar bleibt, benötigen wir 18 Milliarden US-Dollar,
um die nächste dreijährige Förderperiode des Globalen
Fonds finanzieren zu können.
Si queremos cumplir los hitos de la Estrategia del Fondo
Mundial para 2028 y mantener a nuestro alcance la
meta del ODS 3, necesitamos recaudar 18.000 millones
USD para financiar el próximo ciclo de subvenciones
trienal del Fondo Mundial.
Pour franchir toutes les étapes de la stratégie du
Fonds mondial jusqu’en 2028 et nous assurer que la
cible de l'ODD 3 reste à notre portée, nous devons
mobiliser 18 milliards de dollars US pour notre prochain
cycle triennal de subvention.
Dies ist ein entscheidender Moment bei der Bekämpfung von HIV, Tuberkulose (TB) und Malaria. Für unsere achte Wiederauffüllung benötigt der Globale Fonds 18 Milliarden US-Dollar, um 23 Millionen Menschenleben zu retten, die Sterberate der drei Krankheiten um 64 % zu senken und am Aufbau einer We...lt mitzuwirken, die gesünder, sicherer und gerechter ist.
more
Estamos en un momento decisivo de la lucha contra el VIH, la tuberculosis y la malaria. El Fondo Mundial necesita recaudar 18.000 millones USD en la Octava Reposición de Recursos para salvar 23 millones de vidas, reducir en un 64% la tasa de mortalidad de las tres enfermedades, y ayudar a construir... un mundo más saludable, seguro y equitativo.
more
Nous sommes à un moment crucial de la lutte contre le VIH, la tuberculose et le paludisme. Pour sa huitième reconstitution des ressources, le Fonds mondial a besoin de 18 milliards de dollars US pour sauver 23 millions de vies, réduire le taux de mortalité des trois maladies de 64 % et bâtir un... monde en meilleure santé, plus sûr et plus équitable.
more
Private sector engagement opens pathways for a game-changing US$2 billion investment opportunity in the fight against HIV, tuberculosis and malaria.
Overall, harmonisation and innovation should be the
focus of the future direction of DAH and the creation of
a healthy global community. The world needs all hands
on deck if it were to move towards achieving the SDGs,
addressing global health inequalities and improving the
welfare of the global... population, while ensuring that no
one is left behind.
more
To realize Agenda 2030, aid agencies, private philanthropies, and their partners in the Global South need better data to monitor how official development finance (ODF) dollars advance the Sustainable Development Goals (SDGs) and avoid missing the mark. In this report, we summarize the results of a n...ovel effort to tag and analyze 2.7 million ODF projects between 2010-2021 using machine learning to understand their contributions to the SDG thematic areas at a goal
and target level. This time frame is instructive: it compares the last six years of the Millennium Development Goals era and the first six years of the new SDG age, from early optimism to later uncertainty about the resilience of the agenda to drive collective commitments amid unanticipated global shocks.
more
Development assistance for health (DAH) is an important source of financing for health for many low-income and some middle-income countries. Most DAH has predominantly been contributed by high-income countries. However, in the context of economic progress and changing global priorities, DAH contribu...tions from countries of the Global South such as India have gained importance. In this paper, we estimate DAH contributed by India between 2009 and 2020.
more
The faltering of progress towards malaria elimination follows a plateauing in international financing since 2010. Despite calls for increased international financing, this will be hard to achieve. Both developed country donors and developing countries with malaria face severe fiscal constraints in e...xpanding malaria funding in the next few years. Simply exhorting countries to spend more is unlikely to be successful, just as the Abuja declaration was not, and the developing countries with most malaria burden suffer from weaker economic growth and less capacity to increase domestic financing.
more
Countries that are reforming their health systems to progress towards Universal Health Coverage (UHC) need to consider total resource requirements over the long term to plan for the implementation and sustainable financing of UHC. However, there is a lack of detailed conceptualization as to how the ...current health financing mechanisms interplay across health system elements. Thus, we aimed to generate evidence on how to utilize resources from different sources of funds in Africa.
more
Strengthening resilient and sustainable systems for health (RSSH) is central to the Global Fund’s strategy, however questions persist about the Global Fund’s role in the health systems strengthening space, and the extent to which investments are designed to achieve strengthening objectives, or j...ust fill in gaps in the system. This paper reports on findings from the Prospective Country Evaluations (PCE), a multi-country multi-year evaluation of Global Fund support.
more
The global pandemic response has typically followed
cycles of panic followed by neglect. We are now, once
again, in a phase of neglect, leaving the world highly
vulnerable to massive loss of life and economic shocks
from natural or human-made epidemics and pandemics.
Quantifying the size of the... losses caused by large-scale
outbreaks is challenging because the epidemiological
and economic research in this field is still at an early
stage. Research on the 1918 influenza H1N1 pandemic
and recent epidemics and pandemics has shown a range
of estimated losses (panel).
more
In 2021, global life expectancy at birth was 74 years whereas in sub-Saharan Africa it was 66 years. Yet in that same year, $92 per person was spent on health in sub- Saharan Africa, which is roughly one fifth of what the next lowest geographic region—North Africa and Middle East—spent ($379). T...he challenges to healthy lives in sub-Saharan Africa are many while health spending remains low. This study uses gross domestic product, government, and health spending data to give a more complete picture of the patterns of future health spending in sub-Saharan Africa. We analyzed trends in growth in gross domestic product, government health spending, development assistance for health and the prioritization of health in national spending to compare countries within sub-Saharan Africa and globally.
more
One approach to development assistance for health, or health aid, emphasizes the ex ante selection of cost-effective health interventions, an approach that began with the World Development Report (1993) on Investing in Health and has since been adopted by the Effective Altruism community. But just h...ow much of health aid is cost-effective? In this paper, we examine projects in the Organisation for Economic Co-operation and Development (OECD) Creditor Reporting System, the standard dataset that measures and characterizes development assistance for health, for the
years 2019 to 2021, and count the number of projects that refer to interventions from a list of highly cost-effective interventions as defined by the Disease Control Priorities Project, third edition. This exploratory quantitative analysis indicates that 61% of projects used a key word/phrase of a costeffective intervention. There were 11.9 interventions mapped per project on average. There is little evidence that donors tailor the set of interventions to country income levels by cost-effectiveness.
Policymakers may benefit from reviewing the full portfolio of interventions covered by domestic and external resources.
more
The relative priority received by issues
in global health agendas is subjected to impressionistic
claims in the absence of objective methods of assessment
of priority. To build an approach for conducting structured
assessments of comparative priority health issues receive,
we expand the public ...arenas model (2021) and offer a
framework for future assessments of health issue priority
in global and national health agendas.
more
When we presented our analysis of Germany’s role in
global health in 2017 at an event in Berlin, Richard
Horton, the Editor-in-Chief of The Lancet, asked only
half-jokingly whether we could expect Germany to finally
shrug off the habitus of the “reluctant leader” and “step
up”. Back t...hen, the entire team of authors were hesitant
to use the term leadership as a broad label. We decided to
highlight areas where leadership could be observed, but
refrained from using it in the title of our previous study.
7 years later, after a devastating global pandemic, notable
political changes in Germany, and amid a substantially
changed global health landscape, we aim to analyse
Germany’s role in global health once more.
more
As a recognized win–win-win approach to international debt relief, Debt-to-Health(D2H)has successfully translated debt repayments into investments in health-related projects. Although D2H has experienced modifications and periodic suspension, it has been playing an increasingly important role in r...esource mobilization in public health, particularly for low-and middle-income countries deep in debt.
more